PharmaCyte Biotech, Inc.
Insider Reports History
- Location
- Las Vegas, NV
- Signature
- /s/ Joshua N. Silverman, President and CEO
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by PharmaCyte Biotech, Inc.:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Q/C TECHNOLOGIES, INC. | 10%+ Owner | Series H Convertible Preferred Stock | 889,865 | 04 Sep 2025 | Direct | ||
| Q/C TECHNOLOGIES, INC. | 10%+ Owner | Warrants | 889,865 | 14 Nov 2025 | Direct |
Insider Reports Filed by PharmaCyte Biotech, Inc.
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FEMY | FEMASYS INC | 17 Mar 2026 | 0 | $0 | 4 | 10%+ Owner | 18 Mar 2026, 17:00 |
| TNFA | Q/C TECHNOLOGIES, INC. | 04 Sep 2025 | 2 | $0 | 4 | 10%+ Owner | 18 Nov 2025, 16:32 |
| TNFA | MyMD Pharmaceuticals, Inc. | 23 May 2024 | 0 | $0 | 3 | 10%+ Owner | 30 May 2024, 16:05 |
| FEMY | FEMASYS INC | 21 Nov 2023 | 0 | $0 | 3 | 10%+ Owner | 28 Nov 2023, 17:06 |